Closing Bell: Knight Therapeutics Inc down on Monday (GUD)

Today, Knight Therapeutics Inc shares closed at $5.70 after opening the day at $5.82. prices ranged from a low of $5.66 to a high of $5.82.

Shares eased -0.52 percent from the previous day's close of $5.73.

During the day across North America, the TSX Composite closed 0.80% at 22872.65, the S&P 500 closed -0.71% at 5505.00, the Dow Jones Industrial Average closed -0.93% at 40287.53 and the Nasdaq Composite closed -0.81% at 17726.94.

Knight Therapeutics Inc traded under GUD on the Toronto Stock Exchange (TSX).

A total of 61,158 shares was traded during the last trading day, with total trades of 280. On average, Knight Therapeutics Inc has traded 48,821 shares over 5 days and 66,244 year-to-date.

The TSX overall saw 3,734 price advancers against 1,480 declines and 101 unchanged.

During the prior 52 weeks, GUD.TO has traded as high as $6.22 (May 15,2024) and low as $4.35 (October 23,2023). Moreover, the shares have advanced 16.80 percent in 52 weeks, while this year, they have gained 9.83%.

Following today's trading, Knight Therapeutics Inc has a market capitalization of $580.88 million on a float of 101,376 shares outstanding. Its annual EPS is $-0.16.

Knight Therapeutics Inc is a TSX Drug Specialty & Generic company headquartered in Montreal, CAN.

Based on 4.00 analysts, Knight Therapeutics Inc gets an average recommendation of "Moderate Buy" according to Zacks. From those 4 analysts, 3 have buy ratings and 1 analysts gave hold ratings.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..